These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 6291747

  • 41. Macromolecular and cell cycle effects of different classes of agents inducing the maturation of human myeloblastic leukemia (ML-1) cells.
    Craig RW, Frankfurt OS, Sakagami H, Takeda K, Bloch A.
    Cancer Res; 1984 Jun; 44(6):2421-9. PubMed ID: 6586286
    [Abstract] [Full Text] [Related]

  • 42. Induction of human HL-60 leukemic cell differentiation by immune interferon is accompanied by an increase in NADase activity and by a decrease in DNA-binding proteins.
    Borelli TJ, Konno S, Vuolo LL, Quaini F, Wu JM.
    Biochem Int; 1985 Jul; 11(1):61-8. PubMed ID: 2994674
    [Abstract] [Full Text] [Related]

  • 43. Specific expression of heterotrimeric G proteins G12 and G16 during human myeloid differentiation.
    Tenailleau S, Corre I, Hermouet S.
    Exp Hematol; 1997 Aug; 25(9):927-34. PubMed ID: 9257805
    [Abstract] [Full Text] [Related]

  • 44. JWA, a novel signaling molecule, involved in the induction of differentiation of human myeloid leukemia cells.
    Huang S, Shen Q, Mao WG, Li AP, Ye J, Liu QZ, Zou CP, Zhou JW.
    Biochem Biophys Res Commun; 2006 Mar 10; 341(2):440-50. PubMed ID: 16430862
    [Abstract] [Full Text] [Related]

  • 45. Accessory function and interleukin 1 production by human leukemic cell lines.
    Wakasugi H, Harel A, Dokhelar MC, Fradelizi D, Tursz T.
    J Immunol; 1984 Jun 10; 132(6):2939-47. PubMed ID: 6373923
    [Abstract] [Full Text] [Related]

  • 46. Kinetics of appearance of differentiation-associated characteristics in ML-1, a line of human myeloblastic leukemia cells, after treatment with 12-O-tetradecanoylphorbol-13-acetate, dimethyl sulfoxide or 1-beta-D-arabinofuranosylcytosine.
    Takeda K, Minowada J, Bloch A.
    Cancer Res; 1982 Dec 10; 42(12):5152-8. PubMed ID: 6958361
    [No Abstract] [Full Text] [Related]

  • 47. Marked alteration in phosphorylation of the RB protein during differentiation of human promyelocytic HL60 cells.
    Akiyama T, Toyoshima K.
    Oncogene; 1990 Feb 10; 5(2):179-83. PubMed ID: 2320372
    [Abstract] [Full Text] [Related]

  • 48. Coexpression of simple epithelial keratins and vimentin by human mesothelium and mesothelioma in vivo and in culture.
    LaRocca PJ, Rheinwald JG.
    Cancer Res; 1984 Jul 10; 44(7):2991-9. PubMed ID: 6202404
    [Abstract] [Full Text] [Related]

  • 49. Cytoskeletal organization of peripheral blood normal and leukemic lymphocytes and lymphoblasts.
    Schmitt-Gräff A, Chaponnier C, Gabbiani G.
    J Submicrosc Cytol; 1987 Apr 10; 19(2):329-35. PubMed ID: 3298667
    [Abstract] [Full Text] [Related]

  • 50. A new myelomonoblastic cell line (M20): analysis of properties, differentiation, and comparison with other established lines of similar origin.
    Treves AJ, Halperin M, Barak V, Bar-Tana R, Halimi M, Fibach E, Gamliel H, Leizerowitz R, Polliack A.
    Exp Hematol; 1985 May 10; 13(4):281-8. PubMed ID: 3857183
    [Abstract] [Full Text] [Related]

  • 51. Induction of granulocyte differentiation in a human leukemia cell line does not require cell division.
    Prokocimer M, Koeffler HP.
    Haematologia (Budap); 1986 May 10; 19(2):127-32. PubMed ID: 3463527
    [Abstract] [Full Text] [Related]

  • 52. Unassembled (soluble) vimentin in human myeloid leukemia cell line HL60.
    Takahashi N, Breitman TR.
    Eur J Haematol; 1994 Aug 10; 53(2):78-84. PubMed ID: 7522191
    [Abstract] [Full Text] [Related]

  • 53. Alteration of vimentin intermediate filaments expression during differentiation of HL60 and U937 human leukemic cell lines.
    Dellagi K, Brouet JC.
    Leuk Res; 1984 Aug 10; 8(4):611-6. PubMed ID: 6540831
    [Abstract] [Full Text] [Related]

  • 54. A factor inducing differentiation of the human monocytic cell line U-937 produced by 12-O-tetradecanoylphorbol 13-acetate-treated U-937.
    Kurata N, Sawada M, Ito Y, Marunouchi T.
    Jpn J Cancer Res; 1987 Mar 10; 78(3):219-22. PubMed ID: 3106277
    [Abstract] [Full Text] [Related]

  • 55. Abnormal expression of vimentin intermediate filaments in human lymphoid cell lines with deletion or translocation of the distal end of chromosome 8.
    Dellagi K, Brouet JC, Portier MM, Lenoir GM.
    J Natl Cancer Inst; 1984 Jul 10; 73(1):95-100. PubMed ID: 6204097
    [Abstract] [Full Text] [Related]

  • 56. Two-dimensional analysis of metabolically and cell surface radiolabeled proteins of some human lymphoid and myeloid leukemia cell lines. II. Glycosylated and phosphorylated proteins.
    Chorváth B, Duraj J, Sedlák J, Plesková I.
    Neoplasma; 1986 Jul 10; 33(5):565-70. PubMed ID: 3466044
    [Abstract] [Full Text] [Related]

  • 57. Cytoskeleton-associated proteins: their role as cellular integrators in the neoplastic process.
    Bernal SD, Stahel RA.
    Crit Rev Oncol Hematol; 1985 Jul 10; 3(3):191-204. PubMed ID: 2412718
    [Abstract] [Full Text] [Related]

  • 58. Modulation of cell growth and differentiation induced by prostaglandin D2 in the glioma cell line C6.
    Conde B, Tejedor M, Sinues E, Alcala A.
    Anticancer Res; 1991 Jul 10; 11(1):289-95. PubMed ID: 1902073
    [Abstract] [Full Text] [Related]

  • 59. Identification of a population of bipotent stem cells in the HL60 human promyelocytic leukemia cell line.
    Fontana JA, Colbert DA, Deisseroth AB.
    Proc Natl Acad Sci U S A; 1981 Jun 10; 78(6):3863-6. PubMed ID: 6943586
    [Abstract] [Full Text] [Related]

  • 60. Changes in insulin binding activity during myeloid differentiation.
    Palumbo A, Brossa C, Turco G, Pegoraro L.
    Endocrinology; 1983 Mar 10; 112(3):965-70. PubMed ID: 6337051
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.